Altium Capital Management LP Insulet Corp Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $1.09 Million - $1.35 Million	-4,250 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $3.32 Million - $3.92 Million	-12,750 Reduced 75.0%	4,250 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$225.52 - $304.06 $902,080 - $1.22 Million	-4,000 Reduced 19.05%	17,000 $4.67 Million
Q1 2021 May 06, 2021	BUY	$235.95 - $293.05 $1.13 Million - $1.41 Million	4,800 Added 29.63%	21,000 $5.48 Million
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $3.5 Million - $4.31 Million	16,200 New	16,200 $4.14 Million

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.